Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor
James, Angela Joubert, Smith, Catherine C., Litzow, Mark, Perl, Alexander E., Altman, Jessica K., Shepard, Dale, Kadokura, Takeshi, Souda, Kinya, Patton, Melanie, Lu, Zheng, Liu, Chaofeng, Moy, Selina, Levis, Mark J., Bahceci, Erkut
Published in Clinical pharmacokinetics (01.10.2020)
Published in Clinical pharmacokinetics (01.10.2020)
Get full text
Journal Article
PD-1 X CTLA-4 이중특이적 분자와 조합된 B7-H3 항체-약물 접합체의 사용 방법
KOENIG SCOTT, BOHAC GERRY CHESTER, JAMES ANGELA JOUBERT, SCRIBNER JUNIPER A, SUMROW BRADLEY JAMES, LOO DERYK
Year of Publication 27.09.2024
Get full text
Year of Publication 27.09.2024
Patent
Lorigerlimab, a bispecific PD-1×CTLA-4 DART molecule in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A phase 1 expansion (exp) cohort
Luke, Jason J., Sharma, Manish, Chandana, Sreenivasa R, Lugowska, Iwona A., Szczylik, Cezary, Zolnierek, Jakub, Cote, Gregory Michael, Mantia, Charlene, Dziadziuszko, Rafal, Sanborn, Rachel E., Casey, Denise, Long, Lori, Ward, Ashley, Kaminker, Patrick, James, Angela Joubert, Di Pucchio, Tiziana, Cybulska-Stopa, Bożena
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor
James, Angela Joubert, Smith, Catherine C., Litzow, Mark, Perl, Alexander E., Altman, Jessica K., Shepard, Dale, Kadokura, Takeshi, Souda, Kinya, Patton, Melanie, Lu, Zheng, Liu, Chaofeng, Moy, Selina, Levis, Mark J., Bahceci, Erkut
Published in Clinical pharmacokinetics (01.09.2021)
Published in Clinical pharmacokinetics (01.09.2021)
Get full text
Journal Article
Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia
Smith, Catherine Choy, Levis, Mark J., Litzow, Mark Robert, Perl, Alexander E., Altman, Jessica K., Gill, Stan, Yuen, Geoffrey, Bonate, Peter, Kadokura, Takeshi, James, Angela Joubert, Liu, Charles, Nagase, Itsuro, Fisniku, Ogert, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A phase II/III, multicenter, open-label, 3-arm study of gilteritinib, gilteritinib plus azacitidine, or azacitidine alone in the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia (AML) patients ineligible for intensive induction chemotherapy
Cortes, Jorge E., Altman, Jessica, Ritchie, Ellen K., Larson, Richard A., Claxton, David, Minden, Mark D., Goldenberg, Alec, Naoe, Tomoki, Yoon, Sung-Soo, Rousselot, Philippe H., Mueller-Tidow, Carsten, del Castillo, Teresa Bernal, Havelange, Violaine, Ciceri, Fabio, Knopinska-Posluszny, Wanda, Liu, Shufang, Shrivastava, Archita, James, Angela Joubert, Rich, Elizabeth Shima, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
An open-label, randomized phase III study of gilteritinib versus salvage chemotherapy in relapsed or refractory FLT3 mutation-positive acute myeloid leukemia
Perl, Alexander E., Cortes, Jorge E., Strickland, Stephen Anthony, Ritchie, Ellen K., Neubauer, Andreas, Martinelli, Giovanni, Naoe, Tomoki, Pigneux, Arnaud, Rousselot, Philippe H., Röllig, Christoph, Baer, Maria R., Larson, Richard A., James, Angela Joubert, Chen, Caroline, Shu, Lei, Hasabou, Nahla, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase 3, open-label, randomized study of the FLT3 inhibitor gilteritinib versus salvage chemotherapy in adults with first relapse or primary refractory FLT3 mutation-positive acute myeloid leukemia
Perl, Alexander E., Cortes, Jorge E., Strickland, Stephen Anthony, Ritchie, Ellen K., Neubauer, Andreas, Martinelli, Giovanni, Naoe, Tomoki, Pigneux, Arnaud, Rousselot, Philippe H., Röllig, Christoph, Baer, Maria R., Larson, Richard A., James, Angela Joubert, Chen, Caroline, Shu, Lei, Hasabou, Nahla, Bahceci, Erkut
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
COMPOSIÇÕES FARMACÊUTICAS DE 7-(6-(2-HIDROXI-PROPAN-2-IL)PIRIDIN-3-IL)-1-((TRANS)-4-METOXICICLOEXIL)-3,4-DIIDROPIRAZINO [2,3-B]PIRAZIN-2(1H)-ONA, UMA FORMA SÓLIDA DESSA E MÉTODOS DE SEU USO
MAHMOUD S. ASSAF, ANIL MENON, ANGELA JOUBERT JAMES, TERRENCE JOSEPH CONNOLLY, AMANDA NICOLE MIKLOS, KEVIN JOSEPH KLOPFER, WILLIAM WEI-HWA LEONG
Year of Publication 06.09.2022
Get full text
Year of Publication 06.09.2022
Patent
composições farmacêutica de 7-(6-(2-hidroxi-propan-2-il)-1-((trans)-4-metoxicicloexil)-3,4-diidropirazino [2,3-b]pirazin-2(1h)-ona, uma forma sólida dessa e métodos de seu uso
MAHMOUD S. ASSAF, ANIL MENON, ANGELA JOUBERT JAMES, AMANDA NICOLE MIKLOS, TERRENCE JOSEPH CONNOLLY, KEVIN JOSEPH KLOPFER, WILLIAM WEI-HWA LEONG
Year of Publication 13.06.2017
Get full text
Year of Publication 13.06.2017
Patent
composições farmacêutica de 7-(6-(2-hidroxi-propan-2-il)-1-((trans)-4-metoxicicloexil)-3,4-diidropirazino [2,3-b]pirazin-2(1h)-ona, uma forma sólida dessa e métodos de seu uso
MAHMOUD S. ASSAF, ANIL MENON, ANGELA JOUBERT JAMES, AMANDA NICOLE MIKLOS, TERRENCE JOSEPH CONNOLLY, KEVIN JOSEPH KLOPFER, WILLIAM WEI-HWA LEONG
Year of Publication 13.06.2017
Get full text
Year of Publication 13.06.2017
Patent
PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4 METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE
MIKLOS, AMANDA, NICOLE, KLOPFER, KEVIN, JOSEPH, CONNOLLY, TERRENCE, JOSEPH, JAMES, ANGELA, JOUBERT, ASSAF, MAHMOUD, S, LEONG, WILLIAM, WEI-HWA, MENON, ANIL
Year of Publication 28.07.2016
Get full text
Year of Publication 28.07.2016
Patent
PHARMACEUTICAL COMPOSITIONS OF 7 (6 (2 HYDROXYPROPAN 2 YL)PYRIDIN 3 YL) 1 ((TRANS) 4 METHOXYCYCLOHEXYL) 3 4 DIHYDROPYRAZINO [2 3 B]PYRAZIN 2(1H) ONE A SOLID FORM THEREOF AND METHODS OF THEIR USE
CONNOLLY TERRENCE JOSEPH, MIKLOS AMANDA NICOLE, KLOPFER KEVIN JOSEPH, LEONG WILLIAM WEI HWA, MENON ANIL, ASSAF MAHMOUD S, JAMES ANGELA JOUBERT
Year of Publication 23.10.2015
Get full text
Year of Publication 23.10.2015
Patent
Composiciones farmacéuticas de 7-(6-(2-hidroxipropan-2-il)piridin-3-il)-1-((trans)-4-metoxiciclohexil)-3,4-dihidropirazino[2,3-ß]pirazin-1(1h)-ona, una forma sólida de las mismas y métodos de uso
CONNOLLY TERRENCE JOSEPH, LEONG WILLIAM WEI-HWA, MIKLOS AMANDA NICOLE, MENON ANIL, ASSAF MAHMOUD S, KLOPFER KEVIN, JAMES ANGELA JOUBERT
Year of Publication 10.07.2014
Get full text
Year of Publication 10.07.2014
Patent
PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE
MIKLOS, AMANDA, NICOLE, KLOPFER, KEVIN, JOSEPH, CONNOLLY, TERRENCE, JOSEPH, JAMES, ANGELA, JOUBERT, ASSAF, MAHMOUD, S, LEONG, WILLIAM, WEI-HWA, MENON, ANIL
Year of Publication 08.09.2014
Get full text
Year of Publication 08.09.2014
Patent